Cardiac Amyloidosis

 

ALERT: ASNC Issues Statement on How to Use HMDP in Cardiac Amyloidosis Imaging    Shortages of pyrophosphate (PYP), the radiopharmaceutical most commonly used in the U.S. for noninvasive diagnosis of transthyretin (ATTR) cardiac amyloidosis, should not delay imaging in at-risk patients. Instead, ASNC is guiding imagers to use 99mtechnetium (99mTc)-hydroxymethylene diphosphonate (HMDP or HDP) to ensure patients continue receiving prompt evaluation of, and treatment for, cardiac amyloidosis.

ASNC is the premier source for education and quality in the rapidly expanding area of cardiac amyloidosis. Through its initiatives and partnerships, ASNC is supporting a collaborative approach to awareness, early diagnosis and effective treatments that will save lives and improve quality of life for patients with CA.

ASNC is uniquely qualified to provide education, information and advocacy that ensures appropriate referrals for Tc-99m PYP imaging; supports high-quality testing, interpretation and reporting of Tc-99m PYP imaging by imagers; and encourages fair reimbursement of Tc-99m PYP services and approval of CA treatment agents.

Access the latest educational resources and activities including our new app and share with your colleagues! 
 

 ONDEMAND WEBINARS | RESOURCES | PUBLICATIONS
 

---

Upcoming Meetings

Cardiac Amyloidosis: Virtual On The Road in Rochester Cardiac Amyloidosis: Virtual On the Road will convene on Tuesday, June 28 from 7:50 AM - 12:30 PM (US ET). Join us for "Moving from Rarely Recognized to Rarely Missed for this Treatable Malady", chaired by Ronald G. Schwartz, MD, MASNC and Maria L. Mackin, CNMT, BS MS, CNMT ARRT(N).

 

27th Annual Scientific Session and Exhibition of the American Society of Nuclear Cardiology Registration is open! We look forward to seeing you September 8-11, in person at Caribe Royale in Orlando at ASNC2022! ASNC2022 will also be offered virtually for those who cannot attend in person.

---

Exclusive Content for Members!

Access the 11"x17" Cardiac Amyloidosis Flowchart and our Transthyretin Cardiac Amyloidosis: Frequently Asked Questions guide. Not a member? Join ASNC today!

Download our new 11"x17" flowchart designed to guide your clinical assessment of cardiac amyloidosis.
 
Download our Transthyretin Cardiac Amyloidosis: Frequently Asked Questions guide. 

---

Download the Clinical and Quality Resources App Get up-to-date information on cardiac amyloidosis in eight languages: Chinese, English, French, German, Italian, Japanese, Portuguese and Spanish Topics include: Diagnostic criteria and appropriate imaging utilization in cardiac amyloidosis among others Download Now!

Hover over the QR code with your camera to download